Exploratory analysis of interleukin‐38 in hospitalized COVID‐19 patients

INTRODUCTION: A major contributor to coronavirus disease 2019 (COVID‐19) progression and severity is a dysregulated innate and adaptive immune response. Interleukin‐38 (IL−38) is an IL‐1 family member with broad anti‐inflammatory properties, but thus far little is known about its role in viral infec...

Descripción completa

Detalles Bibliográficos
Autores principales: de Graaf, Dennis M., Teufel, Lisa U., de Nooijer, Aline H., van Gammeren, Adriaan J., Ermens, Antonius A. M., Gaál, Ildikó O., Crișan, Tania O., van de Veerdonk, Frank L., Netea, Mihai G., Dinarello, Charles A., Joosten, Leo A. B., Arts, Rob J. W.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9601778/
https://www.ncbi.nlm.nih.gov/pubmed/36301025
http://dx.doi.org/10.1002/iid3.712

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9601778/
https://www.ncbi.nlm.nih.gov/pubmed/36301025
http://dx.doi.org/10.1002/iid3.712

Ejemplares similares